Effect of soluble factors derived from ZR 75.30 breast cancer cells on endothelial activation
- 1 January 2018
- journal article
- research article
- Vol. 11 (2) , 685-694
Abstract
In this study, we analyzed soluble factors secreted by two Estrogen Receptor Positive (ER-alpha) human breast cancer cell lines, ZR 75.30 (luminal B) and MCF7 (luminal A), and evaluated their effect on endothelial activation. The composition of tumoral soluble factors (TSFs) was analyzed by ELISA (Bio-Plex). TSFs from ZR 75.30 cells expressed higher levels of TNF, IFN-gamma, IL-6, and IL-8 compared to TSFs from MCF-7 cells. TSFs from ZR 75.30 cells induced a pro-adhesive phenotype in human umbilical vein endothelial cells (HUVECs), as characterized by increased monocytic cell adhesion, adhesion molecule expression and NF-kappa B activation and decreased I kappa B-alpha expression. Conversely, TSFs from MCF-7 cells exerted none of these effects on HUVECs. We then added TNF, IFN-gamma, IL-6 or IL-8 alone or in combination with TSFs from MCF-7 cells to HUVECs. Only the combinations that included TNF induced endothelial activation. A neutralizing antibody against IL-1 beta (this cytokine was not measured in the ELISA) had a modest blocking effect on cellular adhesion or the expression of adhesion molecules induced by TSFs from ZR 75.30 cells in HUVECs. However neutralizing antibodies against TNF, IFN-gamma, IL-6 or IL-8 had no effect. Our results suggest that although TNF is an inducer of endothelial cell activation, it is not the only molecule that is responsible for this effect in TSFs from ZR 75.30 cells.Keywords
This publication has 41 references indexed in Scilit:
- Crossing the endothelial barrier during metastasisNature Reviews Cancer, 2013
- Effect of aluminium on migratory and invasive properties of MCF-7 human breast cancer cells in cultureJournal of Inorganic Biochemistry, 2013
- Phenotypic Switch in Blood: Effects of Pro-Inflammatory Cytokines on Breast Cancer Cell Aggregation and AdhesionPLOS ONE, 2013
- Expression of CCL18 and interleukin-6 in the plasma of breast cancer patients as compared with benign tumor patients and healthy controls.2011
- Metastasis: from dissemination to organ-specific colonizationNature Reviews Cancer, 2009
- Targeting tumour hypoxia in breast cancerEuropean Journal of Cancer, 2008
- NF-κB and the immune responseOncogene, 2006
- NF-?B translocation and endothelial cell activation is potentiated by macrophage-released signals co-secreted with TNF-? and IL-1?Inflammation Research, 2004
- NF-κB dependent activation of human endothelial cells treated with soluble products derived from human lymphomasCancer Letters, 2003
- Culture of Human Endothelial Cells Derived from Umbilical Veins. IDENTIFICATION BY MORPHOLOGIC AND IMMUNOLOGIC CRITERIAJournal of Clinical Investigation, 1973